{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:10:54Z","timestamp":1783642254486,"version":"3.55.0"},"reference-count":32,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Impaired mitochondrial function is associated with several metabolic diseases and health conditions, including insulin resistance and type 2 diabetes (T2DM), as well as ageing. The close relationship between the above-mentioned diseases and cardiovascular disease (CVD) (diabetic cardiomyopathy and age-related cardiovascular diseases) has long been known. Mitochondria have a crucial role: they are a primary source of energy produced in the form of ATP via fatty acid oxidation, tricarboxylic acid (TCA) cycle, and electron transport chain (ETC), and ATP synthase acts as a key regulator of cardiomyocyte survival. Mitochondrial medicine has been increasingly discussed as a promising therapeutic approach in the treatment of CVD. It is well known that vitamin B3 as an NAD+ precursor exists in several forms, e.g., nicotinic acid (niacin) and nicotinamide (NAM). These cofactors are central to cellular homeostasis, mitochondrial respiration, ATP production, and reactive oxygen species generation and inhibition. Increasing evidence suggests that the nicotinic acid derivative BGP-15 ((3-piperidine-2-hydroxy-1-propyl)-nicotinic amidoxime) improves cardiac function by reducing the incidence of arrhythmias and improves diastolic function in different animal models. Our team has valid reasons to assume that these cardioprotective effects of BGP-15 are based on its NAD+ precursor property. Our hypothesis was supported by an animal experiment where ageing ZDF rats were treated with BGP-15 for one year. Haemodynamic variables were measured with echocardiography to detect diabetic cardiomyopathy (DbCM) and age-related CVD as well. In the ZDF group, advanced HF was diagnosed, whereas the BGP-15-treated ZDF group showed diastolic dysfunction only. The significant difference between the two groups was supported by post-mortem Haematoxylin and eosin (HE) and Masson\u2019s trichrome staining of cardiac tissues. Moreover, our hypothesis was further confirmed by the significantly elevated Cytochrome c oxidase (MTCO) and ATP synthase activity and expression detected with ELISA and Western blot analysis. To the best of our knowledge, this is the first study to demonstrate the protective effect of BGP-15 on cardiac mitochondrial respiration in an ageing ZDF model.<\/jats:p>","DOI":"10.3390\/pharmaceutics14020226","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T21:01:51Z","timestamp":1642626111000},"page":"226","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cardioprotective Role of BGP-15 in Ageing Zucker Diabetic Fatty Rat (ZDF) Model: Extended Mitochondrial Longevity"],"prefix":"10.3390","volume":"14","author":[{"given":"Mate","family":"Kozma","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariann","family":"Bombicz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balazs","family":"Varga","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5818-4557","authenticated-orcid":false,"given":"Daniel","family":"Priksz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7911-055X","authenticated-orcid":false,"given":"Rudolf","family":"Gesztelyi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Tarjanyi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1208-366X","authenticated-orcid":false,"given":"Rita","family":"Kiss","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reka","family":"Szekeres","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Takacs","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akos","family":"Menes","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozsef","family":"Balla","sequence":"additional","affiliation":[{"name":"Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Balla","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Clinical Centre, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Szilvassy","sequence":"additional","affiliation":[{"name":"Department of Oto-Rhino-Laryngology and Head and Neck Surgery, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Szilvassy","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Juhasz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/FJC.0000000000000707","article-title":"Role of Cytochrome p450 and Soluble Epoxide Hydrolase Enzymes and Their Associated Metabolites in the Pathogenesis of Diabetic Cardiomyopathy","volume":"74","author":"Maayah","year":"2019","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopha.2017.08.083","article-title":"Peroxisome proliferator-activated receptors as therapeutic targets for heart failure","volume":"95","author":"Abushouk","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bbamcr.2011.01.014","article-title":"Mitochondrial dysfunction in diabetic cardiomyopathy","volume":"1813","author":"Duncan","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40169-016-0104-7","article-title":"Emerging therapeutic roles for NAD + metabolism in mitochondrial and age-related disorders","volume":"5","author":"Srivastava","year":"2016","journal-title":"Clin. Transl. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/BJ20061638","article-title":"The power to reduce: Pyridine nucleotides-small molecules with a multitude of functions","volume":"402","author":"Pollak","year":"2007","journal-title":"Biochem. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2020.04.008","article-title":"Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy","volume":"31","author":"Pirinen","year":"2020","journal-title":"Cell Metab."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Pet\u0151, \u00c1., K\u00f3sa, D., Feh\u00e9r, P., Ujhelyi, Z., Sinka, D., Vecserny\u00e9s, M., Szilv\u00e1ssy, Z., Juh\u00e1sz, B., Csan\u00e1di, Z., and V\u00edgh, L. (2020). Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome. Molecules, 25.","DOI":"10.3390\/molecules25020429"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1055\/s-0028-1128142","article-title":"Improvement of Insulin Sensitivity by a Novel Drug, BGP-15, in Insulin-resistant Patients: A Proof of Concept Randomized Double-blind Clinical Trial","volume":"41","author":"Kulcsar","year":"2009","journal-title":"Horm. Metab. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0006-2952(99)00418-9","article-title":"BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase","volume":"59","author":"Szabados","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1124\/mol.59.6.1497","article-title":"Effect of Poly(ADP-Ribose) Polymerase Inhibitors on the Ischemia-Reperfusion-Induced Oxidative Cell Damage and Mitochondrial Metabolism in Langendorff Heart Perfusion System","volume":"59","author":"Halmosi","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1016\/j.ajpath.2016.08.008","article-title":"BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle","volume":"186","author":"Kennedy","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1038\/ncomms6705","article-title":"The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice","volume":"5","author":"Sapra","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bombicz, M., Priksz, D., Gesztelyi, R., Kiss, R., Hollos, N., Varga, B., Nemeth, J., Toth, A., Papp, Z., and Szilvassy, Z. (2019). The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy. Molecules, 24.","DOI":"10.3390\/molecules24030586"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sumegi, K., Fekete, K., Antus, C., Debreceni, B., Gallyas, F., Sumegi, B., and Szabo, A. (2017). BGP-15 Protects against Oxidative Stress- or Lipopolysaccharide-Induced Mitochondrial Destabilization and Reduces Mitochondrial Production of Reactive Oxygen Species. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169372"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur. Hear. J. Cardiovasc. Imaging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"H292","DOI":"10.1152\/ajpheart.01362.2006","article-title":"Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: Role of hydronephrosis","volume":"293","author":"Marsh","year":"2007","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1475-2840-8-39","article-title":"Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: Studies using positron emission tomography","volume":"8","author":"Brom","year":"2009","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/eurjhf\/hfr166","article-title":"Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats","volume":"14","author":"Daniels","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Siwy, J., Zoja, C., Klein, J., Benigni, A., Mullen, W., Mayer, B., Mischak, H., Jankowski, J., Stevens, R., and Vlahou, A. (2012). Evaluation of the Zucker Diabetic Fatty (ZDF) Rat as a Model for Human Disease Based on Urinary Peptidomic Profiles. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051334"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ilar.32.3.16","article-title":"Zucker Diabetic Fatty Rat as a Model for Non-insulin-dependent Diabetes Mellitus","volume":"32","author":"Peterson","year":"1990","journal-title":"ILAR J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1250858","DOI":"10.1155\/2021\/1250858","article-title":"BGP-15 Protects against Heart Failure by Enhanced Mitochondrial Biogenesis and Decreased Fibrotic Remodelling in Spontaneously Hypertensive Rats","volume":"2021","author":"Horvath","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cca.2005.10.025","article-title":"Homocysteine and other biochemical parameters in Type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy","volume":"366","author":"Huang","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.redox.2013.07.004","article-title":"Mitochondria-targeted heme oxygenase-1 induces oxidative stress and mitochondrial dysfunction in macrophages, kidney fibroblasts and in chronic alcohol hepatotoxicity","volume":"2","author":"Bansal","year":"2013","journal-title":"Redox Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0020-711X(88)90093-6","article-title":"The physiological significance of heme oxygenase","volume":"20","author":"Abraham","year":"1988","journal-title":"Int. J. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0167-4889(94)90067-1","article-title":"Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage","volume":"1223","author":"Llesuy","year":"1994","journal-title":"Biochim. Biophys. Acta (BBA) Bioenerg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"15687","DOI":"10.1074\/jbc.M510595200","article-title":"Heme Oxygenase-1 Enhances Renal Mitochondrial Transport Carriers and Cytochrome c Oxidase Activity in Experimental Diabetes","volume":"281","author":"Palmieri","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1034\/j.1600-0773.2003.930306.x","article-title":"Carbon Monoxide Specifically Inhibits Cytochrome C Oxidase of Human Mitochondrial Respiratory Chain","volume":"93","author":"Alonso","year":"2003","journal-title":"Pharmacol. Toxicol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.freeradbiomed.2012.07.021","article-title":"Cytochrome c oxidase dysfunction in oxidative stress","volume":"53","author":"Srinivasan","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_30","first-page":"503","article-title":"Study of oxidative stress in type 2 diabetic patients and its relationship with glycated hemoglobin","volume":"29","author":"Goodarzi","year":"2008","journal-title":"Saudi Med. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/ars.2009.2531","article-title":"Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities","volume":"12","author":"Sivitz","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/cvr\/cvv183","article-title":"Mitochondrial complex I defect and increased fatty acid oxidation enhance protein lysine acetylation in the diabetic heart","volume":"107","author":"Vazquez","year":"2015","journal-title":"Cardiovasc. Res."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/2\/226\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:03:50Z","timestamp":1760133830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/2\/226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["pharmaceutics14020226"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14020226","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]}}}